CompoAtlas

OptiFort

OptiFort, licence 80028289: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Naturo Aid Pharmaceutical Inc.
NPN or DIN-HM
80028289
Status
Active licence
Licence date
23 November 2011
Revision date
9 May 2025
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Source : Lutéine(USP)

6.3 mgNot calculated
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Source : Tagetes erecta - Fleur

6.3 mgNot calculated
Vitamine A

Source : Acétate de vitamine A

300.0 mcg EARNot calculated

Non-medicinal ingredients

Microcrystalline cellulose, Palmitate d'ascorbyle, Hypromellose, L-leucine, Pullulane, Fibre de Pyrus malus (Pomme), Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Capsule3.0 Jour(s)

Uses authorised in Canada

Text supplied in English because no French text is available.

OptiFort contains bilberry extract used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy and macular degeneration.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80028289

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line